Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPBAR1 | Q8TDU6 | 6/20 | 0.51 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.47 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.47 |
| ▸ | BRD4 | O60885 | 1/20 | 0.46 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.45 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | FABP7 | O15540 | 1/20 | 0.44 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5227458 | 1.00 | GPBAR1 (0.51) | GPBAR1DDB1CRBNBRD4CREBBP | |
| SCHEMBL8777371 | 0.87 | KMT2A (0.48) | GPBAR1BRD4CREBBPNPC1RAB9A | |
| SCHEMBL24818238 | 0.86 | CRBN (0.53) | GPBAR1DDB1CRBNTSHRGAA | |
| SCHEMBL2245383 | 0.85 | LMNA (0.55) | GPBAR1GAASMN1; SMN2 | |
| SCHEMBL5552455 | 0.81 | MMP1 (0.46) | GPBAR1GLANPC1RAB9A | |
| SCHEMBL24125403 | 0.79 | ALDH1A1 (0.44) | GPBAR1DDB1CRBNGLATSHR | |
| SCHEMBL7369383 | 0.77 | TSHR (0.49) | GPBAR1DDB1CRBNBRD4CREBBP | |
| SCHEMBL148443 | 0.77 | GPBAR1 (0.46) | GPBAR1DDB1CRBNBRD4CREBBP | |
| SCHEMBL27280429 | 0.77 | TSHR (0.49) | GPBAR1DDB1CRBNBRD4CREBBP | |
| SCHEMBL29088638 | 0.77 | ALDH1A1 (0.46) | DDB1CRBNTSHRRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 323 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119699315-A | Storage method of biological tissue material | 上海易桥医疗器械有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-119564933-A | Preparation method of biological tissue material, prepared biological tissue material and application | 上海易桥医疗器械有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-222131935-U | Benzyloxy (BYO) carbonyl succinyl dehydration reaction device for imine production | 四川安派博生物科技有限公司 | 2024-12-10 | — | — | CN | claimed |
| CN-118883784-A | Melilotoin besylate method for detecting pregabalin | 苏州正济药业有限公司 | 2024-11-01 | — | — | CN | claimed |
| CN-118749523-A | Resistant sanitary pest control composition containing oxazine amide and application thereof | 江苏功成生物科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118624792-A | Pretreatment method of organic matter sample and detection method of lysine substances | 首都医科大学 | 2024-09-10 | — | — | CN | claimed |
| CN-118067886-A | Method for measuring content of aging marker carboxymethyl lysine in skin | 广州质量监督检测研究院 | 2024-05-24 | — | — | CN | claimed |
| CN-118063490-A | Preparation method of ampicillin impurity | 梯尔希（南京）药物研发有限公司 | 2024-05-24 | — | — | CN | claimed |
| CN-117658908-A | Spiral charge folder molecule and preparation method and application thereof | 吉林大学 | 2024-03-08 | — | — | CN | claimed |
| CN-116930478-A | Thyroxine fluorescent conjugate and preparation method and application thereof | 迈克生物股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116183733-A | Method for detecting amino acid and derivatives thereof | 首都医科大学 | 2023-05-30 | — | — | CN | claimed |
| CN-114539106-B | Synthetic method of stable isotope labeled taurinamide hydrochloride | 梯尔希（南京）药物研发有限公司 | 2023-05-02 | — | — | CN | claimed |
| CN-114685391-A | Preparation method of tetraazacyclododecane derivative | 苏州美诺医药科技有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114685390-A | Preparation method of gadobutrol derivative | 苏州美诺医药科技有限公司 | 2022-07-01 | — | — | CN | claimed |
| CN-114539106-A | Synthetic method of stable isotope labeled tauryl amine hydrochloride | 梯尔希（南京）药物研发有限公司 | 2022-05-27 | — | — | CN | claimed |
| CN-111056984-A | Synthetic method of benzyloxycarbonyl succinimide | 滨海吉尔多肽有限公司 | 2020-04-24 | — | — | CN | claimed |
| US-20260109714-A1 | PYRIMIDINE-FUSED RING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | GENFLEET THERAPEUTICS SHANGHAI INC (CN) | 2026-04-23 | — | — | US | disclosed |
| EP-4707393-A1 | DOUBLE-STRANDED SIRNA, CONJUGATE THEREOF AND USE THEREOF | CMS Research & Development Pte. Ltd. (SG) | 2026-03-11 | — | — | EP | disclosed |
| CN-1070409-A | Prodrugs activated by targetted catalytic proteins | IGEN INC (US) | 1993-03-31 | — | — | CN | disclosed |
| WO-1993002703-A1 | PRODRUGS ACTIVATED BY TARGETED CATALYTIC PROTEINS | IGEN, INC. (US) | 1993-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260109714-A1 | PYRIMIDINE-FUSED RING COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | KRAS, NRAS, HRAS | GPBAR1 324/4885DDB1 459/4885CRBN 58/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.